Arca
Skip to content
Tools
Tools

Glutamate-gated chloride channel

Protein in Strongyloides stercoralis that 1 drug acts on.

  • Drugs that act on it: 1
  • Approved: 1
  • In phases 1 to 3: 0
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on this target, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Other 1

Approved1

  • Ivermectin

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DrugFurthest stageSponsorModalityActionOpen trials
        IvermectinApprovedMerck & Co. (MSD)OtherModulatorGlutamate-gated chloride channel modulator21

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.
        Efficacy and Safety of Oral Ivermectin for Genital WartsIvermectinNot applicableNot yet recruitingUniversity of Health Sciences LahoreNov 3, 2026
        A Study of Standard of Care Drugs With or Without Ivermectin for Daraxonrasib-Induced Skin Toxicity in People With Pancreatic CancerIvermectinPhase 2RecruitingMemorial Sloan Kettering Cancer CenterOct 26, 2026
        Systemic and Topical Geroprotective Rejuvenation Assessed by START/REST Aging ClocksIvermectinEarly phase 1Enrolling by invitationFrontiers in Bioscience Research Institute and AgingOct 22, 2026
        Follow-up Assessment of Change in Soil-transmitted Helminths Infection Intensity in UgandaIvermectinPhase 3Not yet recruitingJennifer KeiserOct 14, 2026
        Expanding Access to Preventive Chemotherapy Among Mobile and Migrant PopulationsIvermectinNot applicableRecruitingUwemedimo Friday EkpoJul 16, 2026
        Combination Therapies for Trichuris Trichiura Infection in Schoolchildren in HondurasIvermectinPhase 3Not yet recruitingMundo Sano FoundationJun 22, 2026
        Evaluation of the Impact of Oral Ivermectin on Musca Sorbens Flies, Putative Vector of TrachomaIvermectinPhase 4Not yet recruitingLondon School of Hygiene and Tropical MedicineJun 18, 2026
        Ivermectin Combined With Immune Checkpoint Inhibition in Cancer (ICONIC)IvermectinPhase 2Not yet recruitingUniversity of FloridaMar 23, 2026

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2363050, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.